Warning: fopen(/home/virtual/enm-kes/journal/upload/ip_log/ip_log_2025-02.txt): failed to open stream: Permission denied in /home/virtual/lib/view_data.php on line 100 Warning: fwrite() expects parameter 1 to be resource, boolean given in /home/virtual/lib/view_data.php on line 101
1Department of Endocrinology and Metabolism, Ajou University School of Medicine, Suwon, Korea.
2Department of Internal Medicine, Gyeonggi Provincial Medical Center Uijeongbu Hospital, Uijeongbu, Korea.
Copyright © 2014 Korean Endocrine Society
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Values are expressed as mean±SD. BMD1 refers to the first BMD measurement and BMD2 refers to the last BMD measurement during the observation period. The mean observation duration between BMD1 and BMD2 was 56 months.
BMD, bone mineral density.
aComparisons between baseline BMD and follow-up BMD were analyzed by Wilcoxon signed rank test (P<0.05 was considered significant).
BMI, body mass index; DM, diabetes mellitus; HTN, hypertension; IM, intramuscular injection; po, per oral.
Values are expressed as mean±SD. BMI, body mass index; BMD, bone mineral density.
Values are expressed as mean±SD. The mean observation time was 56 months. There was a significant increase in serum testosterone levels during testosterone replacement therapy (
Values are expressed as mean±SD. BMD1 refers to the first BMD measurement and BMD2 refers to the last BMD measurement during the observation period. The mean observation duration between BMD1 and BMD2 was 56 months. BMD, bone mineral density. aComparisons between baseline BMD and follow-up BMD were analyzed by Wilcoxon signed rank test (